From January 13 to 16, Dr. Huiming Li, Deputy General Manager of Kexing Biopharm New Drug Research Center, attended the 17th Biotech Showcase conference in San Francisco and the Global Biopharma ...

We also explore current studies and innovations in nanobody technology. Asthma pathophysiology involves a complex interplay of cytokines and chemokines that orchestrate the immune response, leading to ...

This study aims to design and characterize a PD-1-specific nanobody using an integrated computational and experimental approach. Methods: An in silico design strategy was employed, involving ...

Indian startups Pranos, Anubal Fusion, and Hylenr are advancing efforts in nuclear fusion by exploring different technological methods. These companies aim to overcome engineering challenges, ...

Even once researchers can reliably get more power out of a fusion reaction than they put in, they'll still need to overcome engineering challenges to scale up fusion energy. The experiment ...

KAUST Catalysis Center (KCC), Division of Physical Sciences & Engineering, King Abdullah University of Science and Technology, KAUST, Thuwal 23955, Kingdom of Saudi Arabia ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis ... Advanced disease can lead to progressive and pathologic ...

George R. Tynan has received research funding from the US Department of Energy and the Office of Fusion Energy Sciences, and has served on numerous advisory panels to DOE and the International ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab ... and pathologic bone formation and joint fusion, severely limiting spinal mobility.